Evidence map›Paper›PMID 34830006›Full record

ArticleInternational journal of molecular sciences2021

Discovery of Phenolic Glycoside from

Xingyu Liu, Jie Su, Geng Wang, Lihua Zheng, Guannan Wang, Ying Sun, Yongli Bao, Shuyue Wang, Yanxin Huang

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Pharmacophylogenetic relationships of genusFrontiers in pharmacology · 2024
    Review
  8. (Poly)phenols: The Missing Piece in the Puzzle of Inflammation.International journal of molecular sciences · 2023
    Article
  9. The influence ofFrontiers in pharmacology · 2023
    Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Xingyu LiuNational Engineering Laboratory for Druggable Gene and Protein Screening, Northeast Normal University, Changchun 130117, China.ORCID 0000-0002-9661-5995
Jie SuNational Engineering Laboratory for Druggable Gene and Protein Screening, Northeast Normal University, Changchun 130117, China.
Geng WangNMPA Key Laboratory for Quality Control of Cell and Gene Therapy Medicine Products, Northeast Normal University, Changchun 130117, China.
Lihua ZhengNMPA Key Laboratory for Quality Control of Cell and Gene Therapy Medicine Products, Northeast Normal University, Changchun 130117, China.ORCID 0000-0001-5380-2021
Guannan WangNational Engineering Laboratory for Druggable Gene and Protein Screening, Northeast Normal University, Changchun 130117, China.
Ying SunNational Engineering Laboratory for Druggable Gene and Protein Screening, Northeast Normal University, Changchun 130117, China.
Yongli BaoNational Engineering Laboratory for Druggable Gene and Protein Screening, Northeast Normal University, Changchun 130117, China.
Shuyue WangNational Engineering Laboratory for Druggable Gene and Protein Screening, Northeast Normal University, Changchun 130117, China.
Yanxin HuangNMPA Key Laboratory for Quality Control of Cell and Gene Therapy Medicine Products, Northeast Normal University, Changchun 130117, China.
Northeast Normal University · CN

Funding

Department of Human Resources and Social Security of Jilin Province 2020009Jilin Province Development and Reform Commission 2020C015Natural Science Foundation of Jilin Provience 20180101242JCResearch Foundation of Jilin Province Science & Technology Committee 20200404124YYScientific Research Project of Education Department of Jilin Province JJKH20201177KJ
6 · The paper itself

Abstract

It seems quite necessary to obtain effective substances from natural products against inflammatory response (IR) as there are presently clinical problems regarding accompanying side effects and lowered quality of life. This work aimed to investigate the abilities of hyssopuside (HY), a novel phenolic glycoside isolated from

Indexed as

AnimalsCyclooxygenase 2GlycosidesHumansHyssopus PlantInflammationLipopolysaccharidesMacrophagesMiceNitric Oxide Synthase Type IIRAW 264.7 CellsCyclooxygenase 2GlycosidesLipopolysaccharidesNitric Oxide Synthase Type IINos2 protein, mouseanti-inflammationHyssopus cuspidatushyssopusidemacrophagesNF-κBphenolic glycoside

Identifiers

PMID34830006
PMCPMC8623068
OpenAlexW3212645803

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.